Linden Advisors’s Aspire Biopharma Warrant ASBPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.9K Hold
899,999
﹤0.01% 540
2025
Q4
$17.7K Hold
899,999
﹤0.01% 456
2025
Q3
$25.2K Hold
899,999
﹤0.01% 386
2025
Q2
$40.5K Hold
899,999
﹤0.01% 346
2025
Q1
$65.7K Hold
899,999
﹤0.01% 258
2024
Q4
$36.2K Hold
899,999
﹤0.01% 225
2024
Q3
$34K Hold
899,999
﹤0.01% 209
2024
Q2
$32.6K Hold
899,999
﹤0.01% 225
2024
Q1
$30.5K Hold
899,999
﹤0.01% 251
2023
Q4
$58.5K Hold
899,999
﹤0.01% 226
2023
Q3
$44.6K Hold
899,999
﹤0.01% 266
2023
Q2
$49.5K Hold
899,999
﹤0.01% 266
2023
Q1
$40.5K Hold
899,999
﹤0.01% 335
2022
Q4
$36.6K Hold
899,999
﹤0.01% 428
2022
Q3
$131K Hold
899,999
﹤0.01% 478
2022
Q2
$144K Buy
+899,999
New +$196K ﹤0.01% 510

Other funds holding ASBPW